

IN BRIEF: Hutchmed lung cancer treatment savolitinib approved in China


IN BRIEF: Hutchmed launches Hong Kong IPO; drug candidate approved


(Sharecast News) - Hutchmed China announced the launch of its Hong Kong public offering on Friday, as part of its global offering of 104 million new s...


TRADING UPDATES: Cordiant deploys IPO funds; Scotgold gets loan


TRADING UPDATES: STV looks to summer's football; In The Style sales up


UK shareholder meetings calendar - next 7 days


IN BRIEF: Hutchison China gets USD100 million investment from Baring


IN BRIEF: Hutchison China starts first phase trials for HMPL-306